The Food and Drug Administration has approved what it called the second new drug in two months for a form of leukemia, the agency said Friday.
The Food and Drug Administration has approved a new drug for treating a rare blood and marrow cancer that affects older adults, the agency said Tuesday.
The Food and Drug Administration has approved a new usage for a blood cancer drug,...
A cancer drug made by Bristol-Myers Squibb and Otsuka Pharmaceutical has received priority review from...
The Food and Drug Administration will shorten its review time of a Novartis drug under...